Lisa G Ware

age ~65

from Reston, VA

Get Report

Also known as:

Connected to:

Lisa Ware Phones & Addresses

Name / Title

Company / Classification

Phones & Addresses

Lisa Ware
Director, Vice President

Casa De Vida Homeowner's Association, Inc
Civic/Social Association

609 Soliel Dr, Naples, FL 34110
663 Soliel Dr, Naples, FL 34110
PO Box 8786, Naples, FL 34101
603 Soliel Dr, Naples, FL 34110

Lisa Ware
Director

QUILCEDA CREEK VINTNERS, INC

Lisa Ware
President

Lisa Ware PA
Nonclassifiable Establishments

20412 Larino Loop, Estero, FL 33928

Recombinant Merozoite Protein-1 P42 Vaccine
view source
US Patent:

7150875, Dec 19, 2006
Filed:

Mar 18, 2002
Appl. No.:

10/100699
Inventors:

David E. Lanar - Takoma Park MD, US
Sheetij Dutta - Silver Spring MD, US
Lisa A. Ware - Silver Spring MD, US
Assignee:

The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:

A61K 39/015
A61K 39/00
A61K 39/002
C07H 21/04
C12P 21/02
US Classification:

4242721, 4241921, 4241911, 4241841, 536 231, 536 234, 435 695, 435 697
Abstract:

In this application is the expression and purification of a recombinant (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Plasmodium Falciparum Ama-1 Protein And Uses Thereof
view source
US Patent:

20030138450, Jul 24, 2003
Filed:

Oct 15, 2002
Appl. No.:

10/271145
Inventors:

David Lanar - Takoma Park MD, US
Sheetij Dutta - Silver Spring MD, US
Lisa Ware - Silver Spring MD, US
Lalitha Nair - New Delhi, IN
International Classification:

A61K039/002
C07H021/04
C12N001/10
C12N015/74
C07K014/445
US Classification:

424/191100, 530/350000, 435/069300, 435/320100, 435/258200, 536/023700
Abstract:

In this application is described the expression and purification of a recombinant (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.

Plasmodium Falciparum Ama-1 Protein And Uses Thereof
view source
US Patent:

20060264619, Nov 23, 2006
Filed:

Jan 13, 2006
Appl. No.:

11/332647
Inventors:

David Lanar - Takom Park MD, US
Sheetij Dutta - Silver Spring MD, US
Lisa Ware - Silver Spring MD, US
Lalitha Nair - New Delhi, IN
International Classification:

C07H 21/02
C07H 21/04
US Classification:

536023100
Abstract:

In this application is described the expression and purification of a recombinant (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.

Plasmodium Falciparum Ama-1 Protein And Uses Thereof
view source
US Patent:

20030032787, Feb 13, 2003
Filed:

Mar 25, 2002
Appl. No.:

10/105717
Inventors:

David Lanar - Takoma Park MD, US
Sheetij Dutta - Silver Spring MD, US
Lisa Ware - Silver Spring MD, US
Lalitha Nair - Silver Spring MD, US
International Classification:

C07H021/02
C07H021/04
US Classification:

536/023100
Abstract:

In this application is described the expression and purification of a recombinant (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.